Á¦¸ñ |
|
¼öÇ÷°Ë»çÇÐ
|
|
ÀúÀÚ |
|
±è±âÀ¯ , ±è´ëÀº , ±è´ëÁß , ±èÀºÀç , ¹Ú±¸³² , ¹Ú¹Ì¿µ , ¹Ú»ó³² , ¹Ú»óÁ¤ , ¹ÚÅÂÈ , ¹ÚÈñö , ¼Ûâ¼· , À̶̹õ , À̹ÎÁ¤ , À̼®ÁØ , ÃÖ¼¼¹¬ , ÃÖ¿¬ÀÓ
|
|
|
¿ªÀÚ |
|
|
|
ÃâÆÇ»ç |
|
¹ü¹®¿¡µàÄÉÀÌ
|
|
ISBN |
|
9791159433665
|
|
ÃâÆÇÀÏ |
|
2023³â 03¿ù 15ÀÏ
|
|
ÆÇÇü |
|
215 * 275 mm
|
|
ÆäÀÌÁö¼ö |
|
300ÂÊ
|
|
ÆǸŰ¡°Ý |
|
38,000¿ø
|
|
Information
º» Àú¼´Â ÀÓ»óÇöÀå¿¡¼ ±Ù¹«ÇÏ°í, ÇлýµéÀ» ÁöµµÇÏ¸é¼ ÇÊ¿äÇÑ ³»¿ëÀ» ÇåÇ÷ÇÏ´Â ¼ø°£ºÎÅÍ Ç÷¾×¿ø¿¡¼ Ç÷¾×Á¦Á¦¸¦ ¸¸µé°í ÀÇ·á±â°ü¿¡¼ ¼öÇ÷Çϱâ±îÁöÀÇ °úÁ¤À» ÀÌÇØÇϱ⠽±°Ô ¼³¸íÇÏ°íÀÚ ³ë·ÂÇÏ¿´½À´Ï´Ù.
´Ü¿ø Áß°£¿¡ ÀÌÇظ¦ µ½°íÀÚ tip ºÎºÐÀ» »ðÀÔÇÏ¿´°í, °¢ ´Ü¿øÀÇ ¸¶Áö¸·¿¡´Â ¿¬½À¹®Á¦¸¦ ¼ö·ÏÇÏ¿´À¸¸ç, ÀÇ·á±â°ü¿¡¼ÀÇ ½ÇÁ¦ Áõ·Ê¸¦ Á¦½ÃÇÏ¿© ÀÚ±âÁÖµµÀû ÇнÀÀÇ ¿ª·®À» Å°¿ï ¼ö ÀÖµµ·Ï ÇÏ¿´½À´Ï´Ù.
Contents
¼¹® iii
CHAPTER 01 ¼öÇ÷ÀÇ ¿ª»ç 1
1. ¼öÇ÷À̶õ? 2
2. Ç÷¾× ±³È¯¼úÀÇ ¿ª»ç 2
3. Ç÷¾×ÇüÀÇ ¹ß°ß 3
4. Ç×ÀÀ°íÁ¦ÀÇ ¹ß°ß 4
5. ¿ì¸®³ª¶ó ¼öÇ÷ÀÇ ¿ª»ç 5
6. 2021³â ±¹³» Ç÷¾×»ç¾÷ ÇöȲ 7
¿¬½À¹®Á¦ 12
CHAPTER 02 ÇåÇ÷ÀÚ ¼±º° ¹× äÇ÷ 13
1. ÇåÇ÷ÀÚ ¼±º° 14
2. ÇåÇ÷¼ø¼ 16
3. ÀüÇ÷ äÇ÷ ÈÄ Ç÷¾×ÀÇ °ü¸® 24
4. ÇåÇ÷ ÈÄ ÇåÇ÷ÀÚ °ü¸® 25
5. Ç÷¾×ÀÇ ¿î¼Û 26
6. ÇåÇ÷ Ç÷¾×°Ë»ç 27
7. ºÎÀû°Ý Ç÷¾× °ü¸® 28
¿¬½À¹®Á¦ 32
CHAPTER 03 Ç÷¾×¼ººÐÁ¦Á¦¿Í ¼ººÐäÇ÷ ¹× ¼öÇ÷ ¿ä¹ý 35
1. Ç÷¾×¼ººÐÁ¦Á¦(Blood Components) 36
2. Ç÷¾×¼ººÐäÇ÷(Apheresis) 49
3. ¼öÇ÷ ÀϹÝÁöħ(¼öÇ÷°¡À̵å¶óÀÎ 5ÆÇ) 55
¿¬½À¹®Á¦ 65
CHAPTER 04 ¸é¿ªÇ÷¾×ÇÐ 69
1. ¸é¿ª¹ÝÀÀÀÇ °³¿ä 70
2. ¼öÇ÷¿¡¼ÀÇ ¸é¿ª¹ÝÀÀ: Ç÷¾×Çü Ç׿ø°ú Ç×ü ¹ÝÀÀ 84
3. ¼öÇ÷°ú HLA(Human leukocyte antigen) 97
4. ¼öÇ÷°ú Ç÷¼ÒÆÇ Ç׿ø ¹× Ç×ü 98
5. ¼öÇ÷°ú °ú¸³±¸ Ç׿ø ¹× Ç×ü 99
¿¬½À¹®Á¦ 101
CHAPTER 05 Ç÷¾×Çü 105
1. ABO Ç÷¾×Çü 106
2. ABO ¾ÆÇü(ABO subgroups) 111
3. ABO Ç÷¾×ÇüÀÇ ÆÇÁ¤ 119
4. Rh Ç÷¾×Çü 123
5. ±âŸ Ç÷¾×Çü(Other blood group system) 133
¿¬½À¹®Á¦ 145
CHAPTER 06 »ç¶÷ ¹éÇ÷±¸ Ç׿ø 149
1. ÁÖ¿ä Á¶Á÷ÀûÇÕ¼º º¹ÇÕü(major histocompatibility complex, MHC)¶õ? 150
2. ÁÖ¿äÁ¶Á÷ÀûÇÕ¼º º¹ÇÕü(major histocompatibility complex, MHC)ÀÇ ±â´É 152
3. MHC ºÐÀÚÀÇ ±¸Á¶ 154
4. MHC class À¯ÀüÀÚÀÇ ´ÙÇü¼º(polymorphism) 156
5. HLA¿Í Áúº´°úÀÇ °ü°è 157
6. HLA Ç×ü¿Í ¼öÇ÷ 158
¿¬½À¹®Á¦ 160
CHAPTER 07 ¼öÇ÷ Àü °Ë»ç 161
1. Ç÷¾×ÀºÇà °ËüÀÇ Ãë±Þ¹æ¹ý 162
2. ABO & Rh Ç÷¾×Çü °Ë»ç 163
3. ABO ºÒÀÏÄ¡(Áõ·Ê ¹× Çؼ³) 173
4. ºñ¿¹±âÇ×ü ¼±º° ¹× µ¿Á¤°Ë»ç 179
5. Çױ۷κҸ° °Ë»ç 192
6. ±³Â÷ÀûÇÕ½ÃÇè 198
¿¬½À¹®Á¦ 205
CHAPTER 08 ¼öÇ÷ÀÌ»ó¹ÝÀÀ 207
1. ¼öÇ÷ÀÌ»ó¹ÝÀÀÀ̶õ? 208
2. ¿ëÇ÷¼öÇ÷ÀÌ»ó¹ÝÀÀ(Hemolytic transfusion reaction) 209
3. ºñ¿ëÇ÷ ¼öÇ÷ÀÌ»ó¹ÝÀÀ(Non-hemolytic transfusion reaction) 217
4. ¼öÇ÷ÀüÆļº °¨¿°(Transfusion-transmitted infections, TTI) 224
5. ¼öÇ÷ÀÌ»ó¹ÝÀÀ º¸°íü°è 229
¿¬½À¹®Á¦ 233
CHAPTER 09 ±âŸ °Ë»ç 235
1. Ç×üÈíÂø°Ë»ç(Antibody absorption test): ZZAP 󸮹ý 236
2. Ç×ü ¿ëÃâ°Ë»ç(Antibody elution test) 239
3. Ç×üÇظ®°Ë»ç(Antibody dissociation test): Chloroquine ¹ý 246
4. ÇÑ·©ÀÀÁý¼Ò°Ë»ç(Cold agglutinin test) 248
5. µ¿Á¾ÀÀÁý¼Ò¿ª°¡°Ë»ç(Isoagglutinin titer) 250
6. Rh Ç×ü ¿ª°¡ °Ë»ç(Rh antibody titer) 253
7. Rh Ç¥ÇöÇü °Ë»ç[Rh phenotype (C, c, E, e)] 255
8. µµ³ª½º-¶õÆ®½´Å¸ÀÌ³Ê °Ë»ç(Donath-Landsteiner test) 256
9. ¾àÁ¦À¯¹ß¿ëÇ÷ºóÇ÷ °Ë»ç(Drug-induced hemolytic anemia test) 259
10. ¿øÁÖÀÀÁý¹ý °Ë»ç(Column agglutination test) 262
¿¬½À¹®Á¦ 267
CHAPTER 10 °Ë»ç½Ç Áú°ü¸® 269
1. ¿ÜºÎÁ¤µµ°ü¸®(External quality management) 270
2. ³»ºÎÁ¤µµ°ü¸®(Internal quality management) 270
3. Âü°íÄ¡ ¼³Á¤ ¹× ÀÓ»ó°æ°úÄ¡ °á°úº¸°í 279
¿¬½À¹®Á¦ 281
ã¾Æº¸±â 283
2023-03-06 ¿ÀÈÄ 8:59:42, Á¶È¸¼ö : 281
|